In 2022, VIVA Biotech Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, VIVA Biotech Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2022, the total operational greenhouse gas (GHG) emissions of VIVA Biotech Holdings amounted to 28,888.71 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2021, the total operational greenhouse gas (GHG) emissions of VIVA Biotech Holdings decreased by 22.88%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2022, the total Scope 1 emissions of VIVA Biotech Holdings were 1,404.35 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2021), VIVA Biotech Holdings's Scope 1 emissions increased by 46.58%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2022, VIVA Biotech Holdings reported Scope 2 greenhouse gas (GHG) emissions of 27,484.36 tCOâ‚‚e without specifying the calculation method.
Compared to the previous year (2021), VIVA Biotech Holdings's Scope 2 emissions (Unspecified Calculation Method) fell by 24.7% in 2022, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
In 2022, VIVA Biotech Holdings reported its Scope 2 emissions using an unspecified methodology.